Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2019
[Hypothermic Action of Oseltamivir Not Dependent on Its Anti-influenza Virus Action]Hideki Ono
Clinical Journal of Gastroenterology|July 17, 2015
Long-term monitoring of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradicationKazunari Murakami, Masaaki Kodama, Yoshihumi Nakagawa, et al.
World Journal of Gastroenterology|April 28, 2007
Expression of mutant type-p53 products in H pylori-associated chronic gastritisMasaaki Kodama, Kazunari Murakami, Tadayoshi Okimoto, et al.
Journal of Gastroenterology|May 20, 2011
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpuraRyugo Sato, Kazunari Murakami, Tadayoshi Okimoto, et al.
Expert Review of Anti-Infective Therapy|October 7, 2005
Helicobacter pylori eradication and associated changes in the gastric mucosaKazunari Murakami, Masaaki Kodama, Ryugo Sato, et al.
World Journal of Gastroenterology|January 27, 2006
Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesisMasaaki Kodama, Kazunari Murakami, Ryugo Sato, et al.
Journal of Clinical Gastroenterology|January 23, 2008
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infectionKazunari Murakami, Tadayoshi Okimoto, Masaaki Kodama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Cooperation among pharmaceutical, medical and nursing schools aimed at 6-year pharmaceutical education]Hideki Ono, Yukihisa Kurono
Journal of Gastroenterology and Hepatology|June 11, 2005
Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosaMasaaki Kodama, Toshio Fujioka, Kazunari Murakami, et al.
Pageof 18